Transactions in Connection with Share Buy-back Program
08 avr. 2024 05h44 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 8, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion...
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
03 avr. 2024 01h34 HE
|
Genmab A/S
Company Announcement Genmab to acquire ProfoundBio for USD 1.8 billion in cash Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart...
Transactions in Connection with Share Buy-back Program
02 avr. 2024 03h24 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; April 2, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Transactions in Connection with Share Buy-back Program
25 mars 2024 09h31 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 25, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Completion of share buy-back program
18 mars 2024 05h49 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 18, 2024 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 15, 2024 On February 14, 2024, Genmab...
Genmab Announces Initiation of Share Buy-Back Program
15 mars 2024 08h16 HE
|
Genmab A/S
Company Announcement Repurchase of up to DKK 3.5 billion worth of sharesCompletion expected no later than December 16, 2024 COPENHAGEN, Denmark; March 15, 2024 – Genmab A/S (Nasdaq: GMAB) announced...
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
13 mars 2024 16h58 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 13, 2024 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523,...
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
13 mars 2024 16h53 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 13, 2024 – Genmab A/S (Nasdaq: GMAB) Following Genmab A/S’ Annual General Meeting held on March 13, 2024, the Company’s Board of Directors met to...
Passing of Genmab A/S’ Annual General Meeting
13 mars 2024 11h13 HE
|
Genmab A/S
Company Announcement At Genmab A/S’ Annual General Meeting held today March 13, 2024, the Annual Report for 2023 was approvedDischarge was given to the Board of Directors and the Executive Management...
Transactions in connection with share buy-back program
11 mars 2024 05h42 HE
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; March 11, 2024 – Genmab A/S (Nasdaq: GMAB). On February 14, 2024, Genmab announced the initiation of a share buy-back program to honor our commitments under...